Boston OAIC: A Translational Approach to Function Promoting Therapies
Boston OAIC: A Translational Approach to Function Promoting Therapies
批准号:
10569992
负责人:
SHALENDER BHASIN
金额:
$2.92万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
未结题
起止时间:
2008-09-01 至 2026-06-30
关键词:
AgeAgingAmericanApplications GrantsBiology of AgingBostonCOVID-19 severityCancer Grant Supplements (P30)CapsicumCategoriesDevelopmentDiseaseEducational ActivitiesFundingFutureGeroscienceGoalsGrantHealthIndividualInnate Immune ResponseInterventionKnowledgeLearningLinkLong COVIDManuscriptsMentorsMinorityNicotinamide adenine dinucleotideObservational StudyPaperPathway interactionsPersonal SatisfactionPersonsPhysical FunctionPhysiciansPost-Acute Sequelae of SARS-CoV-2 InfectionProcessResearchResearch Project GrantsResearch SupportResearch TrainingRoleSARS-CoV-2 infectionScientistSeriesSirtuinsStatistical Data InterpretationStructureSupervisionSyndromeTrainingTraining ProgramsTranslatingWorkWritingcareercareer developmentdisabilityeducation researchimprovedmale healthmeetingsnovelprogramsresponsible research conductskillssymposiumtranslational approach
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The objective of this Diversity Supplement is to support the research training and career development of Dr.
Rodrigo Valderrábano, an outstanding minority physician scientist. This Diversity Supplement is linked to the
Research Education Core of the Boston Claude D. Pepper Older Americans Independence Center (OAIC), an
NIA-funded P30 grant (P30AG013679; PI: Shalender Bhasin), whose primary aim is to train future independent
research scientists who have the knowledge and skills to translate fundamental mechanisms of disease and
disability during the aging process into novel interventions that can improve the health, physical function, and
well-being of people as they age. The Boston OAIC grant was recently renewed for a period of 5 years which is
sufficient to support the requested 2 years of research proposed in the supplement. The mentored research
project also is thematically linked to OAIC's focus on function promoting therapies, mechanisms of aging and
geroscience targets, and the role of the sirtuin-NAD pathway in aging and innate immune response. The
Diversity Supplement has two closely linked components:
Supplement Aim 1: A 2-year intensive mentored research training under the supervision of Dr. Shalender
Bhasin in the context of an observational study of the role of nicotinamide adenine dinucleotide (NAD) in
modulating the innate immune response and severity of SARS-CoV-2 infection and its relation to the
development of the post-acute sequelae of COVID-19 (PASC), also known as chronic COVID syndrome.
Supplement Aim 2: A structured, individually-tailored, didactic training well integrated with the training program
of the Boston Pepper Center's Research Education Core.
Dr. Valderrábano will work with his mentor in developing an individualized training plan (IDP) as outlined in the
proposal. This plan will be reviewed and approved by the REC Director, Dr. Lewis Lipsitz. The IDP includes the
following categories: 1) Career and Learning Goals, 2) Responsible Conduct of Research Training, 3)
Coursework, 4) Scientific Meetings and Conferences, 5) Professional Development, 6) Papers and Abstracts,
and 7) Grant application/s. Didactic training includes participating in Boston OACI's educational activities for
REC awardees, Advanced Aging Research Seminar Series (AARTSS), structured activities to develop
manuscript and grant writing skills, coursework in ‘OMICS Principles, and Statistical Analysis and
Interpretation. He also will attend the regular research conferences of the OAIC, Men's Health program, and
the Glenn Center for the Biology of Aging. The proposed research training and career development will
facilitate Dr. Valderrábano's advancement towards an independent research career in aging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled Trial
-
批准号:10430705
-
项目类别:
-
资助金额:$89.97万
-
财政年份:2022
-
负责人:SHALENDER BHASIN
-
依托单位:
NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled Trial
-
批准号:10668324
-
项目类别:
-
资助金额:$86.81万
-
财政年份:2022
-
负责人:SHALENDER BHASIN
-
依托单位:
A Proof of Concept Trial of a Sirtuin-NAD+ Activator in Alzheimer's Disease
-
批准号:10311161
-
项目类别:
-
资助金额:$75.21万
-
财政年份:2021
-
负责人:SHALENDER BHASIN
-
依托单位:
A Proof of Concept Trial of a Sirtuin-NAD+ Activator in Alzheimer's Disease
-
批准号:10457489
-
项目类别:
-
资助金额:$87.31万
-
财政年份:2021
-
负责人:SHALENDER BHASIN
-
依托单位:
A Proof of Concept Trial of a Sirtuin-NAD+ Activator in Alzheimer's Disease
-
批准号:10634622
-
项目类别:
-
资助金额:$88.16万
-
财政年份:2021
-
负责人:SHALENDER BHASIN
-
依托单位:
Improving Quality of Life of Prostate Cancer Survivors with Androgen Deficiency
-
批准号:10398005
-
项目类别:
-
资助金额:$72.19万
-
财政年份:2018
-
负责人:SHALENDER BHASIN
-
依托单位:
Multimodality Intervention to Improve Function and Metabolism in Spinal Cord Injury
-
批准号:9767249
-
项目类别:
-
资助金额:$74.0万
-
财政年份:2018
-
负责人:SHALENDER BHASIN
-
依托单位:
Multimodality Intervention to Improve Function and Metabolism in Spinal Cord Injury
-
批准号:10159744
-
项目类别:
-
资助金额:$103.03万
-
财政年份:2018
-
负责人:SHALENDER BHASIN
-
依托单位:
Multimodality Intervention to Improve Function and Metabolism in Spinal Cord Injury
-
批准号:10398790
-
项目类别:
-
资助金额:$99.83万
-
财政年份:2018
-
负责人:SHALENDER BHASIN
-
依托单位:
Improving Quality of Life of Prostate Cancer Survivors with Androgen Deficiency
-
批准号:9918241
-
项目类别:
-
资助金额:$75.47万
-
财政年份:2018
-
负责人:SHALENDER BHASIN
-
依托单位:
Multimodality Intervention to Improve Function and Metabolism in Spinal Cord Injury
-
批准号:10764596
-
项目类别:
-
资助金额:$44.64万
-
财政年份:2018
-
负责人:SHALENDER BHASIN
-
依托单位:
Improving Quality of Life of Prostate Cancer Survivors with Androgen Deficiency
-
批准号:9750591
-
项目类别:
-
资助金额:$75.47万
-
财政年份:2018
-
负责人:SHALENDER BHASIN
-
依托单位:
Improving Quality of Life of Prostate Cancer Survivors with Androgen Deficiency
-
批准号:10782755
-
项目类别:
-
资助金额:$44.73万
-
财政年份:2018
-
负责人:SHALENDER BHASIN
-
依托单位:
Anti-Geronic Factors, GDF11 and Oxytocin, and Aging-Related Phenotypes
-
批准号:9341419
-
项目类别:
-
资助金额:$23.76万
-
财政年份:2016
-
负责人:SHALENDER BHASIN
-
依托单位:
A selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer
-
批准号:9276519
-
项目类别:
-
资助金额:$68.7万
-
财政年份:2015
-
负责人:SHALENDER BHASIN
-
依托单位:
A selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer
-
批准号:8693498
-
项目类别:
-
资助金额:$73.96万
-
财政年份:2015
-
负责人:SHALENDER BHASIN
-
依托单位:
Muscle Mass and Strength Cutpoints in Persons at Risk of Mobility Disability
-
批准号:9145622
-
项目类别:
-
资助金额:$75.07万
-
财政年份:2015
-
负责人:SHALENDER BHASIN
-
依托单位:
Muscle Mass and Strength Cutpoints in Persons at Risk of Mobility Disability-A1
-
批准号:9472426
-
项目类别:
-
资助金额:$16.46万
-
财政年份:2015
-
负责人:SHALENDER BHASIN
-
依托单位:
A Novel System to Detect Falls in Real-life Conditions
-
批准号:9144707
-
项目类别:
-
资助金额:$75.0万
-
财政年份:2015
-
负责人:SHALENDER BHASIN
-
依托单位:
Randomized Trial of a Multifactorial Fall Injury Prevention Strategy
-
批准号:8768759
-
项目类别:
-
资助金额:$764.55万
-
财政年份:2014
-
负责人:SHALENDER BHASIN
-
依托单位:
海外基金